Impaired astrocytic Ca<sup>2+</sup> signaling in awake-behaving Alzheimer's disease transgenic mice.

Åbjørsbråten, Knut Sindre; Skaaraas, Gry H E Syverstad; Cunen, Céline; Bjørnstad, Daniel M; Binder, Kristin M Gullestad; Bojarskaite, Laura; Jensen, Vidar; Nilsson, Lars N G et al. · Elife · 2022

basic_science · Level V

Where this comes from

Abstract

Increased astrocytic Ca<sup>2+</sup> signaling has been shown in Alzheimer's disease mouse models, but to date no reports have characterized behaviorally induced astrocytic Ca<sup>2+</sup> signaling in such mice. Here, we employ an event-based algorithm to assess astrocytic Ca<sup>2+</sup> signals in the neocortex of awake-behaving tg-ArcSwe mice and non-transgenic wildtype littermates while monitoring pupil responses and behavior. We demonstrate an attenuated astrocytic Ca<sup>2+</sup> response to locomotion and an uncoupling of pupil responses and astrocytic Ca<sup>2+</sup> signaling in 15-month-old plaque-bearing mice. Using the genetically encoded fluorescent norepinephrine sensor GRAB<sub>NE</sub>, we demonstrate a reduced norepinephrine signaling during spontaneous running and startle responses in the transgenic mice, providing a possible mechanistic underpinning of the observed reduced astrocytic Ca<sup>2+</sup> responses. Our data points to a dysfunction in the norepinephrine-astrocyte Ca<sup>2+</sup> activity axis, which may account for some of the cognitive deficits observed in Alzheimer's disease.

Medical subject headings